Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0144821001
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Cancelled Post Market | 00619744 | JANSSEN PHARMACEUTICA, DIVISION OF JANSSEN-ORTHO INC. | SUFENTA INJ 50MCG/ML | Human | No | Narcotic (CDSA I) | 1 | SUFENTANIL (SUFENTANIL CITRATE) | 50 MCG / ML |
Cancelled Post Market | 01951319 | JANSSEN INC | SUFENTA INJ 50MCG/ML | Human | No | Narcotic (CDSA I) | 1 | SUFENTANIL (SUFENTANIL CITRATE) | 50 MCG / ML |
Approved | 02483181 | HIKMA CANADA LIMITED | SUFENTANIL CITRATE INJECTION | Human | Yes | Narcotic (CDSA I) | 1 | SUFENTANIL (SUFENTANIL CITRATE) | 50 MCG / ML |
Marketed | 02244147 | SANDOZ CANADA INCORPORATED | SUFENTANIL CITRATE INJECTION USP | Human | Yes | Narcotic (CDSA I) | 1 | SUFENTANIL (SUFENTANIL CITRATE) | 50 MCG / ML |
Application information
Related information
Contact us
Version 4.0.3